发明名称 RE-DIRECTED IMMUNOTHERAPY
摘要 The invention provides an agent for preventing or treating a condition characterized by the presence of unwanted cells, the agent comprising: (i) a targeting moiety that is capable of targeting to the unwanted cells; and (ii) a T cell antigen, wherein the T cell antigen can be released from the targeting moiety by selective cleavage of a cleavage site in the agent in the vicinity of the unwanted cells.
申请公布号 EP2686020(B1) 申请公布日期 2017.02.22
申请号 EP20120718715 申请日期 2012.03.15
申请人 The University of Birmingham 发明人 COBBOLD, Mark;MILLAR, David
分类号 A61K47/68;A61K39/12;A61K47/65;A61P37/00 主分类号 A61K47/68
代理机构 代理人
主权项
地址